Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations

被引:2
|
作者
Zhang, Ye [1 ,2 ,3 ,4 ,5 ]
Zhou, Zheng [1 ,2 ,3 ,4 ,5 ]
Liu, Xiaoxiao [1 ,2 ,3 ,4 ,5 ]
Zhu, Lijing [1 ,2 ,3 ,4 ,5 ]
Cui, Yajuan [1 ,2 ,3 ,4 ,5 ]
Li, Tie-jun [1 ,2 ,3 ,4 ,5 ]
Zhou, Chuan-Xiang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Peking Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Beijing 100081, Peoples R China
[2] Natl Ctr Stomatol, Beijing, Peoples R China
[3] Natl Clin Res Ctr Oral Dis, Beijing, Peoples R China
[4] Natl Engn Res Ctr Oral Biomat & Digital Med Device, Beijing, Peoples R China
[5] Chinese Acad Med Sci 2019RU034, Res Unit Precis Pathol Diag Tumors Oral & Maxillof, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
salivary mucinous adenocarcinoma; colloid carcinoma; papillary carcinoma; AKT1 E17K mutation; BRAF V600E mutation; CARCINOMA;
D O I
10.1097/PAS.0000000000002164
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The relationship between various patterns of mucin-producing salivary adenocarcinomas, including invasive salivary adenocarcinomas with mucinous differentiation, such as colloid and papillary carcinomas, remains unclear. Herein, we aimed to describe the clinicopathologic characteristics, immunophenotypes, molecular underpinnings, and clinical behavior of salivary mucinous adenocarcinomas (MA) to clarify their classification. We described a broad series of colloid and papillary patterns of MAs, indicating that papillary pattern presented papillary cystic proliferation of mucinous columnar cells as salivary intraductal papillary mucinous neoplasms with recurrent AKT1 E17K mutations, whereas colloid adenocarcinomas containing large mucinous pools or lakes around the malignant epithelial nests or islands harbored BRAF V600E mutations with worse prognosis. Typical morphologic structures, CK7(+), CK20(-), CDX2(-), p63(-), p40(-), MAML2 fluorescence in situ hybridization (-), AR(-), TTF-1(-), S100(-), mammaglobin(-), or S100/mammaglobin(+) with ETV6 fluorescence in situ hybridization (-) immunophenotype, and recurrent AKT1 E17K or BRAF V600E mutations may be defined. To our knowledge, this small series represents the first genetic study on a typical colloid pattern of MA, and our study with the spectrum documentation for MA in clinicopathologic characteristics, histologic and immunophenotypes, molecular features, and clinical behavior will allow for a better understanding of these rare but distinctive tumors.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [1] Biphasic Sinonasal Adenocarcinomas with Recurrent BRAF V600E Mutations: Unique Seromucinous Analogues to Salivary Gland Tumors
    Mikula, Michael
    Seethala, Raja
    Agaimy, Abbas
    Franchi, Alessandro
    Bradova, Martina
    Hang, Jen-Fan
    Hsieh, Min-Shu
    Stelow, Edward
    Bishop, Justin
    Rooper, Lisa
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1334 - S1334
  • [2] Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations
    An, Tongtong
    Wang, Jie
    Bai, Hua
    Wang, Zhijie
    Zhao, Jun
    Duan, Jianchun
    Zhuo, Minglei
    Wu, Meina
    Wang, Yuyan
    Wang, Shuhang
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] BRAF V600E Mutations in Endometrial Adenocarcinoma
    He, Mai
    Breese, Virginia
    Hang, Steven
    Zhang, Cunxian
    Xiong, Jinjun
    Jackson, Cynthia
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2013, 22 (01) : 35 - 40
  • [4] BRAF V600E mutations in papillary craniopharyngioma
    Brastianos, Priscilla K.
    Santagata, Sandro
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (04) : R139 - R144
  • [5] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    LABORATORY INVESTIGATION, 2017, 97 : 327A - 327A
  • [6] High frequency of BRAF V600E mutations in ameloblastoma
    Kurppa, Kari J.
    Caton, Javier
    Morgan, Peter R.
    Ristimaki, Ari
    Ruhin, Blandine
    Kellokoski, Jari
    Elenius, Klaus
    Heikinheimo, Kristiina
    JOURNAL OF PATHOLOGY, 2014, 232 (05): : 492 - 498
  • [7] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    MODERN PATHOLOGY, 2017, 30 : 327A - 327A
  • [8] BRAF V600E mutations in glioneuronal tumours in epilepsy
    Thom, M.
    Schneider, C.
    Paradiso, B.
    Liu, J.
    Reeves, C.
    Pardo-Jardim, A.
    An, S.
    Brandner, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 : 41 - 41
  • [9] BRAF V600E Mutations in Bile Duct Adenomas
    Pujals, Anais
    Amaddeo, Giuliana
    Castain, Claire
    Bioulac-Sage, Paulette
    Compagnon, Philippe
    Zucman-Rossi, Jessica
    Azoulay, Daniel
    Leroy, Karen
    Zafrani, Elie Serge
    Calderaro, Julien
    HEPATOLOGY, 2015, 61 (01) : 403 - 405
  • [10] V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics
    Salimian, Kevan J.
    Fazeli, Roghayeh
    Zheng, Gang
    Ettinger, David
    Maleki, Zahra
    ACTA CYTOLOGICA, 2018, 62 (02) : 79 - 84